Skip to main content

WHO Says No to Remdesivir as COVID-19 Treatment

photo of covid 19 virus

In the new assessment, the WHO panel of experts analyzed data from four international randomized trials that assessed several treatments for COVID-19 and included more than 7,000 hospitalized COVID-19 patients.



from WebMD Health https://ift.tt/2UKRTdt
via IFTTT

Comments

Popular posts from this blog

The Future of Autoimmune Disorders: Psoriatic Disease

What's being done to help people with psoriatic disease? We get a look at the ever-changing picture from a rheumatologist. from WebMD Health https://ift.tt/5P6ZHyd via IFTTT

Long COVID Experts: ‘So Incredibly Clear What’s at Stake’

It’s estimated that more than a third of people who have had COVID-19 experience neurological complications such as brain fog that persist or develop 3 months after infection. And two thirds of so-called long haulers still have neurological symptoms after 6 months. from WebMD Health https://ift.tt/mx1j6QD via IFTTT

Study: Black Men Twice as Likely to Develop Prostate Cancer as Whites

A review of men seen at VA hospitals found that Black veterans had nearly twice the incidence of localized and advanced prostate cancer as white men. from WebMD Health https://ift.tt/3Knscs2 via IFTTT